HLA expression in uveal melanoma: There is no rule without some exception

Human Immunology

Volumn 63, Issue 6, 2002, Pages 444-451

  Jager, Martine J ^a   Hurks, H Monique ^a   Levitskaya, Jelena ^b   Kiessling, Rolf ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

HLA Class I; Immune escape; Oncology; Uveal melanoma

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA A ANTIGEN; HLA B ANTIGEN; HLA G ANTIGEN; HLA-G ANTIGEN;

ALLELE; ANTIGEN EXPRESSION; GENE LOCUS; HAPLOTYPE; HUMAN; METASTASIS; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR ESCAPE; TUMOR GROWTH; TUMOR IMMUNOLOGY; UVEA MELANOMA; GENE; IMMUNOLOGY; MELANOMA; METABOLISM; PATHOLOGY; UVEA; UVEA TUMOR;

GENES, MHC CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MELANOMA; UVEA; UVEAL NEOPLASMS;

EID: 0036597825     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00389-0     Document Type: Article

References (58)

1. Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance
2. Natural history of HLA expression during tumour develoment
3. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
4. Malignant melanomas of the human uvea: 25 Year follow-up of cases in Denmark, 1943-1952
5. Survival in metastatic ocular melanoma
6. HLA-A and HLA-B specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immune-electron micrscopy
7. The HLA crossroad in tumor immunology
8. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
9. Phenotypic dynamics of tumor progression in human malignant melanoma
10. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma
11. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens
12. MHC antigens in human melanomas
13. Immunohistological evaluation of MHC Class I and II antigen expression on nevi and melanoma: Relation to biology of melanoma
14. Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas
15. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma
16. Down-regulation of HLA-class I antigen-processing molecules in malignant melanoma: Association with disease progression
17. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression
18. Differential expression of HLA-A and -B alleles on uveal melanoma as determined by immunohistology
19. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma
20. Human leukocyte antigen class I expression: Marker of poor prognosis in uveal melanoma
21. HLA class I antigen expression corelates with epithelioid cell type in uveal melanoma
22. Association of HLA class I and class II antigen expression and mortality in uveal melanoma
23. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases
24. Expression of HLA class I on ocular melanoma during progression from primary to metastatic disease
25. Loss of HLA class I alleles, heavy chains and beta 2 microglobulin in colorectal cancer
26. Beta 2-microglobulin gene mutations: A study of established colorectal cell lines and fresh tumors
27. Beta2-microglobulin gene mutations in human melanoma cells: Molecular characterization and implications for immune surveillance
28. Frequent loss of hetrozygosity on chromosome 6p in uveal melanoma
29. HLA antigen expression on uveal melanoma cells in vivo and in vitro
30. HLA expression and tumor-infiltrating immune cells in uveal melanoma
31. Inhibition of lymphocyte proliferation by aqueous humor
32. Cutting edge; role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege
33. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells
34. Studies on tumor-infiltrating lymphocytes from a human choroidal melanoma
35. Proteolysis and class I major histocompatibility complex antigen presentation
36. Degradation of cell proteins and the generation of MHC class I-presented peptides
37. Antigen-processing machinery breakdown and tumor growth
38. Reduced expression of TAP-1 and TAP-2 in posterior uveal melanoma is associated with progression to metastatic disease
39. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin
40. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines
41. Unorthodox expression of la-like antigens on human tumor cells of nonlymphoid origin: Immunological properties, structural profile, and clinical relevance
42. In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expression
43. Evaluation of HLA-DR expression and T-lymphocyte infiltration in ostosarcoma
44. Association between HLA expression and infiltration of immune cells in cervical carcinoma
45. Flow cytometric investigation of immune-response-related surface molecules on human colorectal cancers
46. Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo x-ray irradiation
47. + T cells kill HLA-class-II-antigen postive melanoma cells presenting peptide in vivo
48. Regulation of MHC class I and II gene transcriptation: Differences and similarities
49. HLA-G gene polymorphism segregation within CEPH reference families
50. Protection from natural-killer-mediated lysis by HLA-G expression on target cells
51. Theα1 domain of the HLA-G1 and G2 inhibits cytotoxicity induced by natural killer cells. Is HLA-G the public ligand for natural killer inhibitory receptors?
52. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T cell responses
53. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies
54. Expression of HLA-G in human tumors is not a frequent event
55. HLA-G protein expression is not induced during malignant transformation
56. Uveal melanoma: No expression of HLA-G
57. NK sensitivity and lung clearance of MHC-class I deficient cells within a heterogeneous fibrosarcoma
58. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model